Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

An evaluation of emerging vaccines for childhood meningococcal disease.

Choudhuri D, Huda T, Theodoratou E, Nair H, Zgaga L, Falconer R, Luksic I, Johnson HL, Zhang JS, El Arifeen S, Nelson CB, Borrow R, Campbell H, Rudan I.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S29. doi: 10.1186/1471-2458-11-S3-S29. Review.

2.

An evaluation of emerging vaccines for childhood pneumococcal pneumonia.

Webster J, Theodoratou E, Nair H, Seong AC, Zgaga L, Huda T, Johnson HL, Madhi S, Rubens C, Zhang JS, El Arifeen S, Krause R, Jacobs TA, Brooks AW, Campbell H, Rudan I.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S26. doi: 10.1186/1471-2458-11-S3-S26. Review.

3.

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children.

Nair H, Verma VR, Theodoratou E, Zgaga L, Huda T, Simões EA, Wright PF, Rudan I, Campbell H.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S30. doi: 10.1186/1471-2458-11-S3-S30. Review.

4.

An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children.

Higginson D, Theodoratou E, Nair H, Huda T, Zgaga L, Jadhav SS, Omer SB, Rudan I, Campbell H.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S31. doi: 10.1186/1471-2458-11-S3-S31. Review.

5.

An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children.

Huda T, Nair H, Theodoratou E, Zgaga L, Fattom A, El Arifeen S, Rubens C, Campbell H, Rudan I.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S27. doi: 10.1186/1471-2458-11-S3-S27. Review.

6.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Novak RT, Kambou JL, Diomandé FV, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrébéogo SR, Clark TA.

Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18.

7.

An evaluation of the emerging vaccines against influenza in children.

Nair H, Lau E, Brooks W, Seong A, Theodoratou E, Zgaga L, Huda T, Jadhav SS, Rudan I, Campbell H.

BMC Public Health. 2013;13 Suppl 3:S14. doi: 10.1186/1471-2458-13-S3-S14. Epub 2013 Sep 17. Review.

8.

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.

Xie O, Pollard AJ, Mueller JE, Norheim G.

Vaccine. 2013 Jun 12;31(27):2852-61. doi: 10.1016/j.vaccine.2013.04.036. Epub 2013 Apr 24. Review.

PMID:
23623866
9.

Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.

Woods CW, Armstrong G, Sackey SO, Tetteh C, Bugri S, Perkins BA, Rosenstein NE.

Lancet. 2000 Jan 1;355(9197):30-3.

PMID:
10615888
10.

From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.

Aguado MT, Jodar L, Granoff D, Rabinovich R, Ceccarini C, Perkin GW.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S391-5. doi: 10.1093/cid/civ593. Review.

11.

Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.

Carod Artal FJ.

Int Health. 2015 Jul;7(4):226-7. doi: 10.1093/inthealth/ihv025. Epub 2015 Apr 15.

PMID:
25878213
12.

Meningococcal conjugate vaccines.

Zimmer SM, Stephens DS.

Expert Opin Pharmacother. 2004 Apr;5(4):855-63. Review.

PMID:
15102568
13.

Technical Development of a New Meningococcal Conjugate Vaccine.

Frasch CE, Kapre SV, Lee CH, Préaud JM.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S404-9. doi: 10.1093/cid/civ595. Review.

14.

Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.

Tartof S, Cohn A, Tarbangdo F, Djingarey MH, Messonnier N, Clark TA, Kambou JL, Novak R, Diomandé FV, Medah I, Jackson ML.

PLoS One. 2013 May 9;8(5):e63605. doi: 10.1371/journal.pone.0063605. Print 2013.

15.

[Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].

Chippaux JP, Debois H, Saliou P.

Bull Soc Pathol Exot. 2002 Mar;95(1):37-44. Review. French.

PMID:
12012963
16.

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa., Altmann D, Aseffa A, Bash M, Basta N, Borrow R, Broome C, Caugant D, Clark T, Collard JM, Djingarey M, Goldblatt D, Greenwood B, Griffiths U, Hajjeh R, Hassan-King M, Hugonnet S, Kimball AM, LaForce M, MacLennan C, Maiden MC, Manigart O, Mayer L, Messonnier N, Moisi J, Moore K, Moto DD, Mueller J, Nascimento M, Obaro S, Ouedraogo R, Page AL, Perea W, Pluschke G, Preziosi MP, Sow S, Stephens D, Stuart J, Thomson M, Tiendrebeogo S, Trape JF, Vernet G.

Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27.

17.

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.

Mueller JE, Borrow R, Gessner BD.

Expert Rev Vaccines. 2006 Jun;5(3):319-36. Review.

PMID:
16827617
18.

Meningococcal carriage in the African meningitis belt.

MenAfriCar Consortium..

Trop Med Int Health. 2013 Aug;18(8):968-78. doi: 10.1111/tmi.12125. Epub 2013 May 18.

19.

Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.

Mohammed I, Iliyasu G, Habib AG.

Pathog Glob Health. 2017 Feb;111(1):1-6. doi: 10.1080/20477724.2016.1274068. Epub 2017 Jan 12. Review.

PMID:
28081671
20.

The Meningitis Vaccine Project.

LaForce FM, Konde K, Viviani S, Préziosi MP.

Vaccine. 2007 Sep 3;25 Suppl 1:A97-100. Epub 2007 May 7.

PMID:
17521780

Supplemental Content

Support Center